companies developing glp 1 drugs GLP-1 Agonists Weight Loss Market Report, 2025-2030 GLP-1 Revolution Transforms Obesity Treatment
Description
2019;68(Suppl 3):s1106
If you have Type 2 diabetes with obesity, cardiovascular disease, kidney disease, or simply inadequate control on current medications, GLP-1 treatment deserves serious consideration
Using opioids in the 7 to 10 days before you start taking CONTRAVE may cause you to suddenly have symptoms of opioid withdrawal when you take it
Older adults may need dose adjustments or extra monitoring, especially if they have kidney problems or take other medicines
RxSS can optimize any strategy for the plan and member
